BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9918427)

  • 1. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
    Nair S; Mathan M; Ramakrishna BS; Mathan VI
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is immunoproliferative small intestinal disease uncommon in India?
    Ghoshal UC; Chetri K; Banerjee PK; Choudhuri G; Pal BB; Dabadghao S; Dhar K; Naik S; Naik SR
    Trop Gastroenterol; 2001; 22(1):14-7. PubMed ID: 11398237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproliferative small intestinal disease in Greece: presentation of 13 cases including two from Albania.
    Economidou I; Manousos ON; Triantafillidis JK; Vaslamatzis MM; Zafiropoulou R; Papadakis T
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):1029-38. PubMed ID: 16894320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoproliferative small intestinal disease. Report of a case with immunohistochemical and ultrastructural study].
    Arista-Nasr J; Armando-Gamboa ; Hernández-Pando R
    Rev Invest Clin; 1993; 45(3):275-80. PubMed ID: 8210770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoproliferative small intestinal disease (IPSID) in Thailand.
    Pramoolsinsap C; Kurathong S; Atichartakarn V; Nitiyanand P
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):11-7. PubMed ID: 8362283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
    Shih LY; Liaw SJ; Dunn P; Kuo TT
    J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
    Zahner J; Kirchner T; Ott G; Schneider W
    Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoproliferative small-intestinal disease: clinical features and outcome in 30 cases.
    Gilinsky NH; Novis BH; Wright JP; Dent DM; King H; Marks IN
    Medicine (Baltimore); 1987 Nov; 66(6):438-46. PubMed ID: 3683173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoproliferative small intestinal disease (IPSID).
    Pervez S; Mumtaz K; Ullah SS; Akhtar N; Ali N; Aaqil H
    J Coll Physicians Surg Pak; 2011 Jan; 21(1):57-8. PubMed ID: 21276391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease.
    Hubmann R; Kaiser W; Radaszkiewicz T; Fridrik M; Zazgornik I
    Z Gastroenterol; 1995 Apr; 33(4):209-13. PubMed ID: 7793120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we suppress the antigenic stimulus in IPSID for lifelong?
    Celik AF; Pamuk GE; Pamuk ON; Uzunismail H; Oktay E; Doğusoy G
    Am J Gastroenterol; 2000 Nov; 95(11):3318-20. PubMed ID: 11095373
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary immunoproliferative small intestinal disease].
    Nardulli Fernández G; Sukerman V; Marsicano L; Ramón Poleo JR; Hernández D; Almosny I; Olavarría R
    G E N; 1995; 49(3):238-42. PubMed ID: 8598264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malabsorption associated with nonmalignant immunoproliferative small intestinal disease.
    Manousos O; Economidou J; Papademetriou C; Triantaphyllidis J; Constandinidou N; Stathopoulos A
    Digestion; 1987; 36(3):182-8. PubMed ID: 3596077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-heavy chain disease--Mediterranean lymphoma].
    Kaufmann HP; Schmitt W; Seib HJ
    Leber Magen Darm; 1994 Feb; 24(1):32-5. PubMed ID: 8145624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoproliferative small intestinal disease associated with Campylobacter jejuni.
    Lecuit M; Abachin E; Martin A; Poyart C; Pochart P; Suarez F; Bengoufa D; Feuillard J; Lavergne A; Gordon JI; Berche P; Guillevin L; Lortholary O
    N Engl J Med; 2004 Jan; 350(3):239-48. PubMed ID: 14724303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy.
    Rogers P; Hill I; Sinclair-Smith C; Bowie M
    Med Pediatr Oncol; 1988; 16(2):128-31. PubMed ID: 3352536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoproliferative small intestinal disease: prolonged 30-year course without development of lymphoma.
    Lin OS; Gray GM
    Am J Gastroenterol; 2001 Sep; 96(9):2769-74. PubMed ID: 11569710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoproliferative disease of the small intestine. A rare differential diagnosis of Crohn's disease].
    Pohl C; Eidt S; Ziegenhagen D; Kruis W
    Dtsch Med Wochenschr; 1991 Aug; 116(34):1265-9. PubMed ID: 1874129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
    Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
    Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.